1. Home
  2. PMCB vs FLYE Comparison

PMCB vs FLYE Comparison

Compare PMCB & FLYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PMCB
  • FLYE
  • Stock Information
  • Founded
  • PMCB 1996
  • FLYE 2018
  • Country
  • PMCB United States
  • FLYE United States
  • Employees
  • PMCB 2
  • FLYE N/A
  • Industry
  • PMCB Biotechnology: Biological Products (No Diagnostic Substances)
  • FLYE Aerospace
  • Sector
  • PMCB Health Care
  • FLYE Industrials
  • Exchange
  • PMCB Nasdaq
  • FLYE Nasdaq
  • Market Cap
  • PMCB 11.4M
  • FLYE 10.7M
  • IPO Year
  • PMCB N/A
  • FLYE 2024
  • Fundamental
  • Price
  • PMCB $1.64
  • FLYE $0.41
  • Analyst Decision
  • PMCB
  • FLYE
  • Analyst Count
  • PMCB 0
  • FLYE 0
  • Target Price
  • PMCB N/A
  • FLYE N/A
  • AVG Volume (30 Days)
  • PMCB 14.0K
  • FLYE 181.1K
  • Earning Date
  • PMCB 12-24-2024
  • FLYE 02-10-2025
  • Dividend Yield
  • PMCB N/A
  • FLYE N/A
  • EPS Growth
  • PMCB N/A
  • FLYE N/A
  • EPS
  • PMCB 0.74
  • FLYE N/A
  • Revenue
  • PMCB N/A
  • FLYE $30,297,313.00
  • Revenue This Year
  • PMCB N/A
  • FLYE N/A
  • Revenue Next Year
  • PMCB N/A
  • FLYE N/A
  • P/E Ratio
  • PMCB $2.21
  • FLYE N/A
  • Revenue Growth
  • PMCB N/A
  • FLYE 14.77
  • 52 Week Low
  • PMCB $1.39
  • FLYE $0.38
  • 52 Week High
  • PMCB $2.58
  • FLYE $7.62
  • Technical
  • Relative Strength Index (RSI)
  • PMCB 45.24
  • FLYE N/A
  • Support Level
  • PMCB $1.60
  • FLYE N/A
  • Resistance Level
  • PMCB $1.69
  • FLYE N/A
  • Average True Range (ATR)
  • PMCB 0.11
  • FLYE 0.00
  • MACD
  • PMCB -0.00
  • FLYE 0.00
  • Stochastic Oscillator
  • PMCB 40.00
  • FLYE 0.00

About PMCB PharmaCyte Biotech Inc.

PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.

About FLYE Fly-E Group Inc. Common Stock

Fly-E Group Inc is an electric vehicle company that is principally engaged in designing, installing and selling smart electric motorcycles, electric bikes, electric scooters and related accessories under the brand Fly E-Bike. It also provides connectivity solutions and value-added services to their customers.

Share on Social Networks: